Global histone modifications as markers of pancreatic ductal adenocarcinoma prognosis

被引：0
|
作者：
Lu, Y. [1 ]
Kim, L. [1 ]
Frederick, B. [1 ]
Zhang, M. [1 ]
Liao, J. [1 ]
Talamonti, M. [1 ]
Bentrem, D. [1 ]
Rao, S. M. [1 ]
Yang, G. Y. [1 ]
机构：
[1] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA
来源：
LABORATORY INVESTIGATION | 2008年 / 88卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1413
引用
收藏
页码：310A / 310A
页数：1
相关论文
共 50 条
  • [41] Epithelial-Mesenchymal Transition Markers in Pancreatic Ductal Adenocarcinoma
    Cates, Justin M. M.
    Byrd, Robert H.
    Fohn, Laurel E.
    Tatsas, Armanda D.
    Washington, Mary K.
    Black, Candice C.
    PANCREAS, 2009, 38 (01) : E1 - E6
  • [42] SPECIFIC MICRORNA MARKERS ARE IDENTIFIED IN BILE IN PANCREATIC DUCTAL ADENOCARCINOMA
    Zabron, A.
    Frampton, A.
    Krell, J.
    Stebbing, J.
    Castellano, L.
    Khan, S.
    Jiao, L.
    GUT, 2013, 62 : A17 - A17
  • [43] Molecular markers associated with perineural invasion in pancreatic ductal adenocarcinoma
    Zhang, Junfeng
    Fu, Xueliang
    Liu, Dejun
    Yang, Minwei
    Yang, Jianyu
    Huo, Yanmiao
    Liu, Wei
    Hua, Rong
    Sun, Yongwei
    Wang, Jian
    ONCOLOGY LETTERS, 2020, 20 (04)
  • [44] Regulatory role of RNA modifications in the treatment of pancreatic ductal adenocarcinoma (PDAC)
    Chen, Hao
    Luo, Wenhao
    Lu, Xiaoyue
    Zhang, Taiping
    HELIYON, 2023, 9 (11)
  • [45] Candidate diagnostic and prognostic markers for pancreatitis and pancreatic ductal adenocarcinoma
    Wilkie, Thomas M.
    Kantheti, Havish
    FASEB JOURNAL, 2022, 36
  • [46] Histone Modulation by Triptolide Contributes to Cell Death in Pancreatic Ductal Adenocarcinoma
    Kurtom, S.
    Giri, B.
    Ferrantella, A.
    Sethi, V.
    Garg, B.
    Banerjee, S.
    Saluja, A.
    Dudeja, V.
    ANNALS OF SURGICAL ONCOLOGY, 2018, 25 : S123 - S123
  • [47] Glypican-3 and KRT19 are markers associating with metastasis and poor prognosis of pancreatic ductal adenocarcinoma
    Yao, Hongliang
    Yang, Zhulin
    Liu, Ziru
    Miao, Xiongying
    Yang, Leping
    Li, Daiqiang
    Zou, Qiong
    Yuan, Yuan
    CANCER BIOMARKERS, 2016, 17 (04) : 397 - 404
  • [48] THE ROLE OF IMMUNOINFLAMMATORY MARKERS IN THE PROGNOSIS AND RESECTABILITY OF PANCREATIC ADENOCARCINOMA
    Eyff, Tatiana Falcao
    Bosi, Henrique Rasia
    Toni, Mariana Sandrin
    Zilio, Mariana Blanck
    Corso, Carlos Otavio
    Bersch, Vivian Pierri
    Osvaldt, Alessandro Bersch
    ABCD-ARQUIVOS BRASILEIROS DE CIRURGIA DIGESTIVA-BRAZILIAN ARCHIVES OF DIGESTIVE SURGERY, 2018, 31 (02):
  • [49] Global Levels of Histone Modifications Predict Prognosis in Different Cancers
    Seligson, David B.
    Horvath, Steve
    McBrian, Matthew A.
    Mah, Vei
    Yu, Hong
    Tze, Sheila
    Wang, Qun
    Chia, David
    Goodglick, Lee
    Kurdistani, Siavash K.
    AMERICAN JOURNAL OF PATHOLOGY, 2009, 174 (05): : 1619 - 1628
  • [50] Cellular patterns of histone modifications predict clinical prognosis in resectable pancreatic adenocarcinoma: results from RTOG study 9704
    Dawson, David
    Garcia, Miguel
    Dawson, Nicole
    Tze, Shelia
    Seligson, David
    Farrell, James
    Kurdistani, Siavash
    Guha, Chandan
    CANCER RESEARCH, 2008, 68 (09)
12345